Rohr and Columbo Associates   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Bryn Mawr PA United States (2000)

Organization Overview

First Clinical Trial
2012
NCT01730976
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Rohr and Columbo Asthma, Allergy and Immunology Specialists | Rohr and Columbo Asthma, Allergy, and Immunology Specialists | Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.